Publication:
Does Recombinant Human Erythropoietin Affect Plasma Lipids in Hemodialysis Patients?

dc.contributor.authorCengiz, K
dc.date.accessioned2020-06-21T15:53:32Z
dc.date.available2020-06-21T15:53:32Z
dc.date.issued1996
dc.departmentOMÜen_US
dc.description.abstracten_US
dc.identifier.doi10.1159/000189484
dc.identifier.endpage732en_US
dc.identifier.issn0028-2766
dc.identifier.issue4en_US
dc.identifier.pmid8956312
dc.identifier.startpage731en_US
dc.identifier.urihttps://doi.org/10.1159/000189484
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22692
dc.identifier.volume74en_US
dc.identifier.wosWOS:A1996VW35600018
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.journalNephronen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleDoes Recombinant Human Erythropoietin Affect Plasma Lipids in Hemodialysis Patients?en_US
dc.typeLetteren_US
dspace.entity.typePublication

Files